Ardelyx Stock Trading Halted Today; FDA Advisory Committee to Discuss XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. ASO
6. QCOM
7. IRT
8. SPY
9. EVMN
10. AAPL

Go back to Ardelyx Stock Trading Halted Today; FDA Advisory Committee to Discuss XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

Ardelyx (ARDX) Kidney Drug Wins FDA Panel Backing as Monotherapy - Bloomberg

November 16, 2022 3:58 PM EST

Ardelyx (NASDAQ: ARDX) Kidney Drug Wins FDA Panel Backing as Monotherapy - Bloomberg

... More